Ligand validation:6QLW

J5T: ~{N}-[(2~{S})-1-[(3~{R},3~{a}~{R},6~{R},6~{a}~{S})-6-chloranyl-3-oxidanyl-2,3,3~{a},5,6,6~{a}-hexahydrofuro[3,2-b]pyrrol-4-yl]-4-methyl-1-oxidanylidene-pentan-2-yl]-4-[5-fluoranyl-2-(4-methylpiperazin-1-yl)-1,3-thiazol-4-yl]benzamide

J5T is a Ligand Of Interest in 6QLW designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6QLW_J5T_D_301	83%	31%	0.093	0.95	1.09	1.75	2	8	0	0	100%	0.95
6QLW_J5T_B_301	75%	36%	0.104	0.937	0.76	1.84	1	8	0	0	100%	0.95
6QLW_J5T_A_301	73%	40%	0.106	0.933	1.02	1.35	2	6	0	0	100%	0.95
6QLW_J5T_C_301	70%	42%	0.111	0.928	1.1	1.19	2	5	0	0	100%	0.95

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.